P2RX7 and glioma: The growth of human high-grade gliomas was inhibited by P2X7 subtype antagonists (Kan et al., 2020); receptor inhibitors, such as emodin, and the Uncaria tomentosa extract effectively counteracted the P2X7 receptor-mediated breast cancer spread (Zhu et al., 2021).